Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis
Journal of Clinical Oncology, 04/25/2012Weide B et al.
The presence of circulating T cells responding to Melan–A or NY–ESO–1 had strong independent prognostic impact on survival in advanced melanoma. The findings support the therapeutic relevance of Melan–A and NY–ESO–1 as targets for immunotherapy
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.